366 related articles for article (PubMed ID: 25799995)
1. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.
Chen Z; Shojaee S; Buchner M; Geng H; Lee JW; Klemm L; Titz B; Graeber TG; Park E; Tan YX; Satterthwaite A; Paietta E; Hunger SP; Willman CL; Melnick A; Loh ML; Jung JU; Coligan JE; Bolland S; Mak TW; Limnander A; Jumaa H; Reth M; Weiss A; Lowell CA; Müschen M
Nature; 2015 May; 521(7552):357-61. PubMed ID: 25799995
[TBL] [Abstract][Full Text] [Related]
2. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling.
Gary-Gouy H; Bruhns P; Schmitt C; Dalloul A; Daëron M; Bismuth G
J Biol Chem; 2000 Jan; 275(1):548-56. PubMed ID: 10617650
[TBL] [Abstract][Full Text] [Related]
3. Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
Sarmay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1997 Jun; 57(1-3):159-64. PubMed ID: 9232445
[TBL] [Abstract][Full Text] [Related]
4. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
[TBL] [Abstract][Full Text] [Related]
5. SHP2 is required for BCR-ABL1-induced hematologic neoplasia.
Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG
Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122
[TBL] [Abstract][Full Text] [Related]
6. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.
Rickert RC
Nat Rev Immunol; 2013 Aug; 13(8):578-91. PubMed ID: 23883968
[TBL] [Abstract][Full Text] [Related]
7. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity.
Khalil AM; Cambier JC; Shlomchik MJ
Science; 2012 Jun; 336(6085):1178-81. PubMed ID: 22555432
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
9. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.
Duy C; Hurtz C; Shojaee S; Cerchietti L; Geng H; Swaminathan S; Klemm L; Kweon SM; Nahar R; Braig M; Park E; Kim YM; Hofmann WK; Herzog S; Jumaa H; Koeffler HP; Yu JJ; Heisterkamp N; Graeber TG; Wu H; Ye BH; Melnick A; Müschen M
Nature; 2011 May; 473(7347):384-8. PubMed ID: 21593872
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
[TBL] [Abstract][Full Text] [Related]
11. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
Geng H; Hurtz C; Lenz KB; Chen Z; Baumjohann D; Thompson S; Goloviznina NA; Chen WY; Huan J; LaTocha D; Ballabio E; Xiao G; Lee JW; Deucher A; Qi Z; Park E; Huang C; Nahar R; Kweon SM; Shojaee S; Chan LN; Yu J; Kornblau SM; Bijl JJ; Ye BH; Ansel KM; Paietta E; Melnick A; Hunger SP; Kurre P; Tyner JW; Loh ML; Roeder RG; Druker BJ; Burger JA; Milne TA; Chang BH; Müschen M
Cancer Cell; 2015 Mar; 27(3):409-25. PubMed ID: 25759025
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Masuda T; Maeda S; Shimada S; Sakuramoto N; Morita K; Koyama A; Suzuki K; Mitsuda Y; Matsuo H; Kubota H; Kato I; Tanaka K; Takita J; Hirata M; Kataoka TR; Nakahata T; Adachi S; Hirai H; Mizuta S; Naka K; Imai Y; Kimura S; Sugiyama H; Kamikubo Y
Cancer Sci; 2022 Feb; 113(2):529-539. PubMed ID: 34902205
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
McCaig AM; Cosimo E; Leach MT; Michie AM
Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
[TBL] [Abstract][Full Text] [Related]
14. Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a.
DeBell KE; Simhadri VR; Mariano JL; Borrego F
BMC Immunol; 2012 Apr; 13():23. PubMed ID: 22537350
[TBL] [Abstract][Full Text] [Related]
15. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
Sármay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
[TBL] [Abstract][Full Text] [Related]
16. Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.
Gu S; Chan WW; Mohi G; Rosenbaum J; Sayad A; Lu Z; Virtanen C; Li S; Neel BG; Van Etten RA
Blood; 2016 Apr; 127(14):1803-13. PubMed ID: 26773044
[TBL] [Abstract][Full Text] [Related]
17. Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.
Feldhahn N; Klein F; Mooster JL; Hadweh P; Sprangers M; Wartenberg M; Bekhite MM; Hofmann WK; Herzog S; Jumaa H; Rowley JD; Müschen M
J Exp Med; 2005 Jun; 201(11):1837-52. PubMed ID: 15939795
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
Boer JM; den Boer ML
Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
20. Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
Rozsnyay Z; Sarmay G; Gergely J
Immunol Lett; 1995 Jan; 44(2-3):149-56. PubMed ID: 7541023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
